Publication: Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction
dc.contributor.author | ÇETİN, MUSTAFA | |
dc.contributor.author | Akgul, Ozgur | |
dc.contributor.author | Erturk, Mehmet | |
dc.contributor.author | Uyarel, Huseyin | |
dc.contributor.author | Bulut, Umit | |
dc.contributor.author | Akkaya, Emre | |
dc.contributor.author | Buturak, Ali | |
dc.contributor.author | Surgit, Ozgur | |
dc.contributor.author | Fuat, Ali | |
dc.contributor.author | Yildirim, Aydin | |
dc.date.accessioned | 2020-10-22T20:21:50Z | |
dc.date.available | 2020-10-22T20:21:50Z | |
dc.date.issued | 2014-11-01T00:00:00Z | |
dc.description.abstract | Objectives The aim of this study was to evaluate the prognostic value of soluble CD40 ligand (sCD40L) in patients with ST-segment elevation myocardial infarction (STEMI) undergoing a primary percutaneous coronary intervention (PCI). | |
dc.identifier.citation | Pusuroglu H., Akgul O., Erturk M., Uyarel H., Bulut U., Akkaya E., Buturak A., Surgit O., Fuat A., ÇETİN M., et al., -Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.25, ss.558-564, 2014 | |
dc.identifier.doi | 10.1097/mca.0000000000000142 | |
dc.identifier.pubmed | 25004238 | |
dc.identifier.scopus | 84927692146 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12645/24713 | |
dc.identifier.wos | WOS:000343123400005 | |
dc.title | Predictive value of elevated soluble CD40 ligand in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction | |
dc.type | Article | |
dspace.entity.type | Publication | |
local.avesis.id | de824c29-82f0-4f01-bf6e-18aacd2d053b | |
local.indexed.at | PubMed | |
local.indexed.at | WOS | |
local.indexed.at | Scopus | |
local.publication.isinternational | 1 |